Effect of Desflurane on Cardiac Function During Cardiac Surgery: Tissue Doppler Imaging of Mitral Valve Annular Velocity
NCT02003885 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2015-03-06
Summary
The purpose of this study is to determine desflurane's dose-dependent effect on left ventricular (LV) function in cardiac surgery. The change of tissue Doppler imaging (TDI) of lateral mitral valve annular velocity at three different desflurane concentrations would be analyzed by using intraoperative transesophageal echocardiography (TEE) in cardiac surgery patients
Conditions
- Valvular Heart Disease
Interventions
- DRUG
-
increment of desflurane
After achieving stable hemodynamics and BIS 40-60 with desflurnae 0.5 MAC and remifentanil 0.7-1.0 mcg/kg/min (T1), data including S', E', A', EF, E, A and BIS are determined. After 10 min exposure to the increased desflurane dosage 1.0 MAC (T2), data are determiend. After 10 min exposure to the increased desflurane dosage 1.5 MAC (T3), data are determined. Reduction of BP is managed by the increment of phenylephrine infusion
Sponsors & Collaborators
-
Konkuk University Medical Center
lead OTHER
Principal Investigators
-
Tae-Yop Kim, MD, PhD · Konkuk University Medical Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction
NCT04117009 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction
NCT04308031 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation
NCT03570047 ·Status: COMPLETED
-
Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract
NCT03587558 ·Status: UNKNOWN ·Phase: PHASE4
-
Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
NCT02623049 ·Status: UNKNOWN
-
The Safety of Vardenafil in Patients Undergoing Cardiac Surgery
NCT01260285 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients
NCT01621971 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy
NCT03380520 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy
NCT01188369 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
NCT05350969 ·Status: COMPLETED ·Phase: PHASE2
-
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
NCT02750319 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery
NCT06251453 ·Status: UNKNOWN
-
Study of the Acute Effects of Triheptanoin in Heart Failure
NCT01787851 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life
NCT05991128 ·Status: UNKNOWN ·Phase: PHASE4
-
Iron Intravenous Therapy in Reducing the Burden of Severe Arrhythmias in Heart Failure With Reduced Ejection Fraction
NCT04974021 ·Status: UNKNOWN
-
Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery
NCT05838846 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Levosimendan in High Risk Heart Valve Surgery
NCT00154115 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
NCT05971732 ·Status: UNKNOWN ·Phase: PHASE4
-
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
NCT06979375 ·Status: RECRUITING ·Phase: PHASE2
-
Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction
NCT02046044 ·Status: UNKNOWN ·Phase: PHASE4
-
A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure
NCT01944683 ·Status: COMPLETED ·Phase: PHASE1
-
Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure
NCT05177822 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
NCT00202579 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI
NCT07138508 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Concentrations of Amiodarone in Fat Tissue During Chronic Treatment
NCT00313443 ·Status: COMPLETED ·Phase: PHASE4